Internship

Materials Intern

Posted on 7/31/2024

Neuralink

Neuralink

501-1,000 employees

Develops brain-computer interfaces for medical use

Compensation Overview

$35/hr

Fremont, CA, USA

Category
Design Engineering
Mechanical Maintenance and Reliability Engineering
Mechanical Engineering
Required Skills
CAD
SolidWorks
Requirements
  • Fundamental knowledge of how material properties are governed by their molecular structure and impacted by different stressors to assess material performance and durability
  • Experience with standard mechanical testing equipment (e.g., tensile tester, DMA)
  • Experience with mechanical design and CAD software (e.g., SolidWorks)
Responsibilities
  • Evaluating and testing the mechanical properties of implant materials under various adverse conditions to evaluate their performance and longevity
  • Operating high-precision testing instruments, including dynamic mechanical analyzers and micro-FTIR spectrometers
  • Modeling the behavior and longevity of materials using finite elements analysis or similar computational methods to predict performance under stress
  • Collaborating with interdisciplinary teams to design custom fixtures and develop high-throughput testing equipment for yield and longevity assessment, incorporating accelerated aging and mechanical fatigue testing protocols
  • Designing, managing, and conducting experiments using characterization and testing platforms to identify failure modes and root-cause failure mechanisms of medical device and materials
  • Leveraging the understanding of materials structure-property relationships to interpret experimental results and design future experiments
Desired Qualifications
  • Familiarity with failure analysis and mechanical modeling methods (e.g., FEA, COMSOL)

Neuralink develops brain-computer interfaces (BCIs) that enable direct communication between the brain and external devices. Their main product, the N1 Implant, is a small, fully implantable device that allows users to control computers or mobile devices through their brain activity. The N1 Implant operates using a wirelessly charged battery and advanced chips that process neural signals, which are then sent to a dedicated application that translates these signals into commands. What sets Neuralink apart from competitors is its focus on both medical applications for individuals with mobility issues and the potential for cognitive enhancement for a broader audience. The company's goal is to restore autonomy to those with medical needs while also exploring the possibilities of human-computer interaction.

Company Size

501-1,000

Company Stage

Series E

Total Funding

$1.3B

Headquarters

Fremont, California

Founded

2016

Simplify Jobs

Simplify's Take

What believers are saying

  • Neuralink raised $650 million in Series E funding to expand patient access.
  • The FDA granted 'breakthrough' status for Neuralink's speech restoration device.
  • Advancements in AI-driven neural signal decoding enhance Neuralink's device performance.

What critics are saying

  • Ethical concerns about brain-machine interfaces could lead to public backlash.
  • Competing technologies from companies like Synchron and Kernel may outpace Neuralink.
  • The complexity and cost of N1 Implant surgeries may limit accessibility.

What makes Neuralink unique

  • Neuralink's N1 Implant is a fully implantable, cosmetically invisible brain-machine interface.
  • The surgical robot developed by Neuralink ensures precise and minimally invasive implantation.
  • Neuralink's technology translates brain activity into computer commands, restoring autonomy to users.

Help us improve and share your feedback! Did you find this helpful?

Benefits

An opportunity to change the world and work with some of the smartest and the most talented experts from different fields.

Growth potential. We rapidly advance team members who have an outsized impact.

Excellent medical, dental, and vision insurance through a PPO plan; parental leave.

Flexible time off + paid holidays.

Equity + 401(k) plan.

Commuter Benefits.

Meals provided.

Growth & Insights and Company News

Headcount

6 month growth

-3%

1 year growth

0%

2 year growth

0%
Tech Gist Africa
Jun 15th, 2025
Neuralink Raises $650M for Brain Implants

Neuralink, Elon Musk's neurotechnology company, raised $650 million in a Series E funding round. The funds will expand patient access, develop new brain implant devices, and enhance clinical trials. Neuralink's technology, tested in patients with severe paralysis, allows control of devices via thoughts. The FDA granted "breakthrough" status for its speech restoration device. Investors include ARK Invest, Sequoia Capital, and others. Neuralink's pre-funding valuation was approximately $9 billion.

Breaking The News
Jun 12th, 2025
Neuralink raises $649M in equity financing

Neuralink Corp., led by CEO Jared Birchall, has raised $649 million in an equity sale, as revealed in an SEC filing. The sale took place on May 30, 2025, with a minimum investment of $12,019 required from outside investors. The company did not disclose its revenue range.

CNBC
Jun 3rd, 2025
5 things to know before the stock market opens Tuesday

Neuralink, Elon Musk's brain tech startup, said it has closed a $650 million funding round led by ARK Invest, Founders Fund, Sequoia Capital, Thrive Capital, Lightspeed Venture Partners and others.

Goo News
Jun 3rd, 2025
Neuralink Raises $650M in Funding Round

Neuralink, led by Elon Musk, raised $650 million in a Series E funding round, with participation from at least 11 investment firms, including Ark Investment Management and Sequoia Capital. The company plans to use the funds to expand patient access and develop next-generation devices that enhance the connection between biological intelligence and AI. Neuralink is valued at $9 billion. Since the last funding round in August 2023, five patients with severe paralysis have used its devices.

ITmedia
Jun 2nd, 2025
Neuralink Raises $650M in Series E

Neuralink, founded by Elon Musk in 2016, announced on June 2 that it raised $650 million in a Series E funding round. Investors included ARK Invest, Founders Fund, Sequoia Capital, and Thrive Capital. The company is conducting clinical trials, including implanting brain chips in five severely paralyzed patients, and has started trials at major neurosurgical institutions. The funding will expand clinical trials and accelerate innovation in future devices connecting biology and AI.

INACTIVE